Premarket analyst action - healthcare

|By:, SA News Editor

Albireo Pharma (NASDAQ:ALBO) initiated with Buy rating and $35 price target by Needham.

Acadia Healthcare (NASDAQ:ACHC) initiated with Outperform rating by William Blair.

Heron Therapeutics (NASDAQ:HRTX) initiated with Buy rating by Aegis Capital.

Inovio Pharmaceuticals (NYSEMKT:INO) initiated with Buy rating by Aegis.

Aduro Biotech (NASDAQ:ADRO) initiated with Outperform rating by Cowen.

Intellia Therapeutics (NASDAQ:NTLA), Editas Medicine (NASDAQ:EDIT) and CRISPR Therapeutics (NASDAQ:CRSP) initiated with Market Perform ratings by Oppenheimer.

Impax Labs (NASDAQ:IPXL) upgraded to Neutral from Underweight by Piper Jaffray.

Quidel (NASDAQ:QDEL) upgraded to Buy from Hold with a $42 price target by Canaccord Genuity. Upgraded to Outperform by William Blair.

Intuitive Surgical (NASDAQ:ISRG) price target raised to $950 from $800 by RBC Capital Markets on expectations of Q2 beat and higher procedure growth guidance.Maintains Sector Perform rating.

Paratek Pharma (NASDAQ:PRTK) price target raised to $43 from $36 by H.C. Wainwright after positive OASIS-2 data.